Status:
COMPLETED
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
Lead Sponsor:
Centre Hospitalier Henri Duffaut - Avignon
Conditions:
Breast Cancer
Colo-rectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There are several types of circulating DNA: DNA from patient's existing cells, foetal DNA in the case of pregnant woman, and tumoral DNA in the case of patients with cancer. These circulating tumoral ...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Signed consent
- Women with invasive breast carcinoma, NOS, with a radiologically measurable tumor of more than 10 mm (stade I to III)
- Patients with invasive colorectal adenocarcinoma with a radiologically measurable tumor of more than 10 mm (stade I to III)
- Patients who primary surgery is planned
Exclusion
- Neoadjuvant chemotherapy or neoadjuvant radiotherapy
- Other cancer
- BMI \> 30
- Pregnant woman
- Patients under protective administration or deprived of liberty
Key Trial Info
Start Date :
June 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04104633
Start Date
June 14 2018
End Date
June 1 2021
Last Update
January 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Henri Duffaut
Avignon, France, 84000